FDA seeks input on strategic plan to prevent drug shortages

AHA News Now

The Food and Drug Administration seeks comments through March 14 on issues related to developing a strategic plan to prevent and mitigate drug shortages, as required by the FDA Safety and Innovation Act of 2012. An internal FDA task force developing the plan, which is expected to address shortages of both drug and biological products, seeks input on ways to facilitate expansion of manufacturing capacity and better manage and communicate about shortages, among other issues. For more information, see the FDA notice.

Keyword Search